µÏÍþ¹ú¼Ê

µÏÍþÖÆµÏÍþ¹ú¼Ê µÏÍþÖÆµÏÍþ¹ú¼Ê

¼ò ¤™
  • ¼ò
  • ·±
  • EN
¤œ
Ïà¹ØÁ´½Ó
  • ½­ËÕºÀÉ­µÏÍþ¹ú¼ÊÒµ¼¯ÍÅÓÐÏÞ¹«Ë¾¥Y
ÐÂÎÅ·¢²¼
Press Release
Ê×Ò³  >  ÐÂÎÅÖÐÐÄ  >  ÐÂÎÅ·¢²¼
µÏÍþÖÆµÏÍþ¹ú¼ÊÅàĪɳëÄÈ«¹úÊ׳¡ÉÏÊлá˳ÀûÕÙ¿ª
·¢²¼ÈÕÆÚ£º2024/03/29
×ÖºÅ

2024Äê3ÔÂ27ÈÕ£¬µÏÍþÖÆµÏÍþ¹ú¼ÊÊ¥ÂÞÀ³?£¨ÅàĪɳëÄ×¢ÉäÒº£©È«¹úÊ׳¡ÉÏÊлáôßÉöÐÔÆ¶Ñª¹æ·¶ÕïÁƸ߷åÂÛ̳»ª¶«Õ¾ÔÚÉϺ£Â¡ÖؾÙÐС£À´×Ô»ª¶«µØÇøµÄ¶àλÉöÄÚ¿Æ×¨¼Ò³öϯÂÛ̳£¬Î§ÈÆÎÒ¹úÉöÐÔÆ¶ÑªµÄ¹ÜÀíÏÖ×´¡¢µÏÍþ¹ú¼ÊÎïÑо¿Õ¹¿ªÉîÈëÌÖÂÛ£¬²¢¶ÔÎÒ¹ú×ÔÖ÷Ñз¢µÄÉöÐÔÆ¶ÑªÈ«Ð»úÖÆÖÎÁƵÏÍþ¹ú¼ÊÎ¡ªÅàĪɳëĵÄ×÷ÓûúÖÆ¡¢ÁÙ´²Ñо¿½øÐÐÁË·ÖÏí½²½â¡£


   

ר¼ÒÖ¸³ö£¬ÎÒ¹úÂýÐÔÉöÔಡ£¨CKD£©»¼Õ߯¶Ñª»¼²¡Âʸߣ¬ÉöÐÔÆ¶ÑªÊÇCKD×î³£¼ûµÄ²¢·¢Ö¢Ö®Ò»£¬ÇÒËæ×ÅÉö¹¦ÄܵIJ»¶ÏϽµ£¬ÉöÐÔÆ¶ÑªµÄ»¼²¡Âʲ»¶ÏÉý¸ß£¬µ½ÁË͸Îö½×¶Î£¬¾ø´ó¶àÊý»¼Õߣ¨>90%£©´æÔÚÆ¶ÑªÇé¿ö¡£ÉöÐÔÆ¶ÑªÏÔÖøÔö¼ÓCKD»¼ÕßÐÄѪ¹Üʼþ¡¢×äÖС¢Éö²¡½øÕ¹¼°ËÀÍö·çÏÕ£¬ËäÈ»¶ÌÐ§ÖØ×éÈËEPO£¨rHuEPO£©ÔÚÁÙ´²Ê¹ÓöàÄ꣬µ«Ä¿Ç°µÄ´ï±êÂÊÈÔÓдýÌá¸ß£¬Òò´ËÑз¢³¤Ð§ÖƼÁ£¬³ÖÐøÐÔ¡¢¸ßÑ¡ÔñÐÔEPOÊÜÌ弤¶¯¼Á£¬¼õÉÙ×¢Éä´ÎÊýÊÇδÀ´ÉöÐÔÆ¶ÑªµÄÖÎÁÆ·½Ïò¡£



ÅàĪɳëÄÊÇÒ»ÖÖȫлúÖÆµÄEPOÄ£ÄâëÄ£¬×¨¼Ò·Ö±ð´Ó×÷ÓûúÖÆ¡¢½á¹¹Ìص㼰ÊÜÌ嶯Á¦Ñ§½Ç¶È£¬½²ÊöÁËÅàĪɳëÄΪÎÒ¹úCKDÉöÐÔÆ¶Ñª»¼Õß´øÀ´µÄ»ñÒæ¡£


¡¾ÅàĪɳëÄ×÷ÓûúÖÆ¡¿

ÅàĪɳëĶÀÌØ½á¹¹ÓÅÊÆÄܹ»ÔöÇ¿Æä¶ÔEPOÊÜÌåµÄ¸ßÇ׺ÍÁ¦ºÍ¸ßÑ¡ÔñÐÔ£¬Ò»·½Ã棬Æä¶Ô³Æ¶þ¾ÛÌå½á¹¹Äܹ»¸ßЧרһµØ¼¤¶¯EPO´ÙºìÊÜÌ壨ͬÐͶþ¾ÛÌ壩£¬´Ó¶ø³ÖÐø¼¤»îÉýºìͨ·£»ÁíÒ»·½Ã棬Æä¶ÔEPO·Ç´ÙºìÊÜÌ壨Òì¶þ¾ÛÌ壩µÄµÍÇ׺ÍÁ¦ÓÐÖú½µµÍÍѰÐЧӦ´øÀ´µÄ°²È«ÐÔ·çÏÕ¡£´ËÍ⣬ÅàĪɳëĵķÖ×ӽṹÖв»º¬ÓÎÀëÀµ°±ËᣬÒò´Ë²»»áÏñrHuEPOÄÇÑù·¢Éú°±¼×õ£»¯¶øÊ§È¥´Ùºì×÷Óã»ÅàĪɳëĵÄëÄÁ´ÓëEPOÎÞ°±»ùËáÐòÁÐͬԴÐÔ£¬Òò´Ë²»»áÓÕµ¼²úÉúEPO¿¹Ì壬ÓÐÖú¸ÄÉÆEPOµÖ¿¹£¬²¢´ÓÔ´Í·ÉϽµµÍ´¿ºìϸ°ûÔÙÉúÕϰ­ÐÔÆ¶Ñª£¨PRCA£©µÄ·çÏÕ¡£


´ÓÊÜÌ嶯Á¦Ñ§½Ç¶ÈÀ´¿´£¬ÅàĪɳëÄʵÏÖ³¤Ð§´ÙºìµÄÔ­ÒòÔÚÓÚHb³Ö¾ÃÎȶ¨´ï±êÈ¡¾öÓÚά³ÖEPOÊÜÌåÊʶȼ¤»îµÄʱ¼ä£¬¶ø²»ÊǶÌʱ¼¤»îµÄÇ¿¶È¡£Ñо¿ÏÔʾ£¬Ïà±È¶ÌЧrHuEPOºÍ´ïÒÀ²´Í¡£¬EPOÄ£ÄâëÄÓëEPO´ÙºìÊÜÌå½áºÏʱ¼ä¸ü³¤£¬ÓëÊÜÌåÐγɸ߶ÈÎȶ¨µÄ½áºÏ£¬Õâ¿ÉÄÜÊÇÆäʵÏÖ³¤Ð§´ÙºìµÄÔ­ÒòÖ®Ò»£»ÁÙ´²Ñо¿ÖÐҲ֤ʵÅàĪɳëÄÿÔÂÒ»´ÎÄܹ»³ÖÐø´Ùºì£¬ÊµÏÖHb¡¢¼ÁÁ¿Ë«Îȶ¨£¬Õ⽫ΪCKDÉö²¡Æ¶Ñª»¼Õß´øÀ´Îȹ̻ñÒæ¡£ 


2023Äê10Ô£¬È«Çò¶¥¼âҽѧÆÚ¿¯¡¶ÁøÒ¶µ¶¡·(The Lancet)×Ó¿¯eClinicalMedicine(IF:15.1)£¬ÔÚÏß·¢±íÁËÅàĪɳëÄ¢óÆÚÁÙ´²Ñо¿ÂÛÎÄ£¬Ñо¿½øÒ»²½Ö¤ÊµÅàĪɳëÄÁÆÐ§ºÍ°²È«ÐÔ·ÇÁÓÓÚrHuEPO£¬ÇÒÐÄѪ¹Üʼþ·¢ÉúÂʵÍ¡£


¡¾eClinicalMedicine ·¢±íµÄÅàĪɳëÄ¢óÆÚÑо¿½á¹û¡¿

ÕâÏîËæ»ú¡¢¿ª·ÅÐÔ¡¢ÑôÐÔµÏÍþ¹ú¼ÊÎï¶ÔÕÕ¡¢·ÇÁÓЧÐÔ¢óÆÚÊÔÑéÔÚÖйú 43 ¼Ò͸ÎöÖÐÐÄ¿ªÕ¹£¬ÄÉÈë 372 Àý¼ÈÍùʹÓ󣹿 EPO ÖÆ¼ÁµÄ CKD 5 ÆÚ͸Îö»¼Õß¡£½á¹û֤ʵÿÔ 1 ´ÎƤÏÂ×¢ÉäÅàĪɳëÄÓë³£¹æÃ¿ÖÜ 1¡«3 ´Î¶ÌЧrHuEPO¸øµÏÍþ¹ú¼ÊͬÑùÓÐЧÇÒ°²È«¡£ËäÈ»ÊÇ·ÇÁÓЧÑо¿£¬µ«ÔÚÖ÷ÒªÁÆÐ§Öյ㣨´Ó»ùÏßÖÁÁÆÐ§ÆÀ¹ÀÆÚѪºìµ°°×ˮƽµÄƽ¾ù±ä»¯£©ÉÏÏÔʾ³öÓÅЧÐÔÇ÷ÊÆ£¨×é¼ä²îÒ죺0.288 g/dL£¬95% CI£º0.107¡«0.468£¬P = 0.0018£©¡£ÔÚ´ÎÒªÁÆÐ§ÖÕµãÉÏ£¬ÅàĪɳëÄ×éºÍ¶ÌЧrHuEPO×é·Ö±ðÓÐ 63.95% ºÍ 59.65% µÄ»¼ÕßÁÆÐ§ÆÀ¹ÀÆÚ¦¤Hb ά³ÖÔÚ ± 1.0 g/dLÄÚ£¨P = 0.4456£©¡£

   

Ŀǰ£¬ÅàĪɳëÄÒѾ­½øÈë¹ú¼ÒÒ½±£Ä¿Â¼£¬ÎªÎÒ¹úCKDÉöÐÔÆ¶Ñª»¼ÕßÇÐʵ´øÀ´¸ü¸ßЧ¡¢°²È«¡¢±ã½ÝµÄ´´Ð½â¾ö·½°¸£¬´ó´ó¼õÇáÁË»¼Õß¼°Æä¼ÒÍ¥¡¢Éç»áµÄ¼²²¡¸ºµ£¡£µÏÍþÖÆµÏÍþ¹ú¼Ê½«Ê¼ÖÕ±ü³Ð¡°³ÖÐø´´Ð£¬Ìá¸ßÈËÀàÉúÃüÖÊÁ¿¡±µÄʹÃü£¬Óøü¶àÍ»ÆÆÐÔ¡¢¸ßÆ·ÖʵĴ´ÐµÏÍþ¹ú¼ÊÔ츣¹ã´ó»¼Õß¡£


¹ØÓÚÊ¥ÂÞÀ³?

Ê¥ÂÞÀ³?£¨ÅàĪɳëÄ×¢ÉäÒº£©ÊǵÏÍþÖÆµÏÍþ¹ú¼Ê×ÔÖ÷Ñз¢µÄ¡°È«ÇòΨһ»ñÅúÉÏÊеÄEPOÄ£ÄâëÄ¡±£¬2023Äê6Ô»ñ¹ú¼ÒµÏÍþ¹ú¼ÊÆ·¼à¶½¹ÜÀí¾Ö(NMPA)Åú×¼ÉÏÊУ¬ÊÊÓÃÓÚÖÎÁÆÒòÂýÐÔÉöÔಡ£¨CKD£©ÒýÆðµÄƶѪ£¬°üÀ¨Î´½ÓÊܺìϸ°ûÉú³É´Ì¼¤¼Á£¨ESA£©ÖÎÁƵijÉÈË·Ç͸Îö»¼Õߣ¬¼°ÕýÔÚ½ÓÊܶÌЧ´Ùºìϸ°ûÉú³ÉËØ£¨EPO£©ÖÎÁƵijÉÈË͸Îö»¼Õß(±¾Æ·²»ÊÊÓÃÓÚÔÚÐèÒªÁ¢¼´¾ÀÕýƶѪµÄ»¼ÕßÖÐÌæ´úºìϸ°ûÊä×¢)¡£

Ê¥ÂÞÀ³?ÊǵÏÍþÖÆµÏÍþ¹ú¼Ê»ñÅúÉÏÊеĵÚ7¿î´´ÐµÏÍþ¹ú¼Ê£¬Ò²ÊǵÏÍþÖÆµÏÍþ¹ú¼ÊÊ׿îͬʱ»ñÅúÁ½ÏîÊÊÓ¦Ö¢µÄ´´ÐµÏÍþ¹ú¼Ê¡£


¹ØÓÚµÏÍþÖÆµÏÍþ¹ú¼Ê

µÏÍþÖÆµÏÍþ¹ú¼ÊÊÇÖйúÁìÏȵĴ´ÐÂÇý¶¯ÐÍÖÆµÏÍþ¹ú¼ÊÆóÒµ£¬ÏÂÊôºÀÉ­µÏÍþ¹ú¼ÊÒµ¡¢³£Öݺã°îµÏÍþ¹ú¼ÊÒµ¡¢µÏÍþÉúÎïÒ½µÏÍþ¹ú¼ÊµÈ×Ó¹«Ë¾£¬ÖØµã¹Ø×¢¿¹Ö×Áö¡¢¿¹¸ÐȾ¡¢ÖÐÊàÉñ¾­ÏµÍ³¡¢´úл¼°×ÔÉíÃâÒßµÈÖØ´ó¼²²¡ÖÎÁÆÁìÓò£¬ÖÂÁ¦ÓÚͨ¹ý³ÖÐø´´ÐÂÌá¸ßÈËÀàÉúÃüÖÊÁ¿¡£½ØÖÁĿǰ£¬¹«Ë¾ÒÑÉÏÊÐ7¿î´´ÐµÏÍþ¹ú¼Ê£¬´´Ð²úÆ·ÓªÊÕÕ¼±ÈÍ»ÆÆÖÁ67.9%¡£¹«Ë¾Á¬Ðø¶àÄêλ¾ÓÈ«ÇòÖÆµÏÍþ¹ú¼ÊÆóÒµ°ÙÇ¿¡¢ÖйúÒ½µÏÍþ¹ú¼ÊÑз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóҵǰ3Ç¿£¬Êǹú¼ÒÖØµã¸ßм¼ÊõÆóÒµ¡¢¹ú¼Ò¼¼Êõ´´ÐÂʾ·¶ÆóÒµ¡£¹«Ë¾ÓÚ2019Äê6ÔÂÔÚÏã¸ÛÁª½»Ëù¹ÒÅÆÉÏÊУ¨¹ÉƱ´úÂ룺03692.HK£©¡£¸ü¶àÐÅÏ¢Çë·ÃÎÊ£º/¡£


¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿